Oral procedure.
Conditions
Interventions
Intervention 1: Intervention group: Intrabuccal ketamine 3 mg/kg. Intervention 2: Control group: Oral midazolam 0.5 mg/kg.
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 12 Years
Inclusion criteria
Inclusion criteria: Required oral procedures Take informed consent
Exclusion criteria
Exclusion criteria: Sensitivity to benzodiazepines Low blood pressure Having a lung disease Having Nervous-Muscular Disorders Known contraindications to study drug
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation level of the patient. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.;Blood oxygen saturation level. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.;The time interval from taking the drugs to the adequate sedation. Timepoint: Every 5 minutes after drug administered. Method of measurement: Record time.;The time interval from taking the drug to the child's full consciousness. Timepoint: Every 5 minutes after drug administered. Method of measurement: Record time.;The parents' satisfaction. Timepoint: After the child's consciousness. Method of measurement: Question from parents.;Pulse rate per minute. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam.;Respiratory rate per minute. Timepoint: Every 5 minutes after drug administered. Method of measurement: Physical exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarhad Heydari
Esfahan University of Medical Sciences
Outcome results
None listed